Hand Outs Annual Meeting 2022
Powerpoint Slide For Download
Thank you for a great NSGO Annual Meeting 2022 in Helsinki
Topic: Ovarian Cancer
Wednesday March 30 2022
NSGO Symposium:
Role of Immunotherapy in Relapsed Endometrial Cancer
supported by


Molecular classification of endometrial cancer: is it necessary?
Iain McNeish, UK
Role of Immunotherapy in relapsed disease
Jalid Sehouli, GER
Managing the toxicity of novel agents
Antonio Gonzalez Martin, ESP
Thursday March 31 2022
Early detection and diagnosis
Renee Turzanski Fortner, GER
Screening and early detection: Standard of care and beyond standard
Usha Menon, UK
Diagnostics: Standard of care and beyond standard
Daniela Fischerova, CZK
Various
6th Ovarian Cancer Consensus Conference
Mansoor Raza Mirza, DK
Mansoor Raza Mirza, DK
ESGO improving the care of our patients
Nicole Concin, AUT
NSGO Symposium:
Real World Characterization of First-line Ovarian Cancer
supported by

Treatment decisions with the available options
Andreas du Bois, GER
Molecular classification to guide targeted therapy
Iain McNeish, UK
Molecular testing (BRCA, HRD …) – the Nordic initiative
Anniina Färkkilä, FIN
How can we use Real World data to guide the treatment?
Christina Fotopoulou, UK
Friday April 1 200
Chemotherapy and targeted therapeutics – Front line
Sandro Pignata, IT
Iain McNeish, UK
Antonio Gonzalez Martin, ESP
Chemotherapy and targeted therapeutics – Recurrence
NSGO Symposium:
Maintenance PARP inhibitor therapy in Ovarian Cancer
supported by

Maintenance therapy: available options
Sandro Pignata, IT
Domenica Lorusso, IT
Pro sequencing the two options (PARPi, Bevacizumab)
Antonio Gonzalez Martin, ESP
What are the treatment options for patients progressed on/after PARP inhibitors?
Frederic Marmé, GER